National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (2020) Breast cancer. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf Accessed Feb 11 2020

Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risk of breast, ovarian and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402–2416

Article  PubMed  CAS  Google Scholar 

Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

Article  PubMed  PubMed Central  CAS  Google Scholar 

Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, Eng C, Pal T, Cullinane CA, Couch FJ, Kotsopoulos J, Sun P, Lubinski J, Narod SA (2023) The risks of cancer in older women with BRCA pathogenic variants: how far have we come? Cancer 129(6):901–907. https://doi.org/10.1002/cncr.34615

Article  PubMed  CAS  Google Scholar 

Phi XA, Houssami N, Obdeijn IM et al (2015) Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers > age 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 33:349–356

Article  PubMed  Google Scholar 

Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Hooning MJ, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, Tilanus-Linthorst MM, van den Heuvel ER, Houssami N (2016) Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer 114(6):631–637. https://doi.org/10.1038/bjc.2016.32

Article  PubMed  PubMed Central  CAS  Google Scholar 

Elmore JG, Armstrong K, Lehman CD et al (2005) Screening for breast cancer. JAMA 293:1245–1256

Article  PubMed  PubMed Central  CAS  Google Scholar 

Houssami N, Ciatto S, Irwig L et al (2002) The comparative sensitivity of mammography and ultrasound in women with breast symptoms: an age specific analysis. Breast 11:125–130

Article  PubMed  CAS  Google Scholar 

Checka CM, Chun JE, Schnabel FR, Lee J, Toth H (2012) The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198(3):W292–W295. https://doi.org/10.2214/AJR.10.6049

Article  PubMed  Google Scholar 

Brennan ME, Houssami N, Lord S et al (2009) Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and metaanalysis of incremental cancer detection and impact on surgical management. J Clin Oncol 27(33):5640–5649

Article  PubMed  Google Scholar 

Yadav S, Boddicker NJ, Na J, Polley EC, Hu C, Hart SN, Gnanaolivu RD, Larson N, Holtegaard S, Huang H, Dunn CA, Teras LR, Patel AV, Lacey JV, Neuhausen SL, Martinez E, Haiman C, Chen F, Ruddy KJ, Olson JE, John EM, Kurian AW, Sandler DP, O’Brien KM, Taylor JA, Weinberg CR, Anton-Culver H, Ziogas A, Zirpoli G, Goldgar DE, Palmer JR, Domchek SM, Weitzel JN, Nathanson KL, Kraft P, Couch FJ (2023) Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol 41(9):1703–1713. https://doi.org/10.1200/JCO.22.01239

Article  PubMed  PubMed Central  CAS  Google Scholar 

Malone KE et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. JCO 28:2404–2410. https://doi.org/10.1200/JCO.2009.24.2495

Article  CAS  Google Scholar 

Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, Offit K, Robson ME (2016) Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol 13(9):581–588. https://doi.org/10.1038/nrclinonc.2016.90

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giannakeas V, Narod SA (2018) The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy. Breast Cancer Res Treat 167(1):263–267. https://doi.org/10.1007/s10549-017-4476-1

Article  PubMed  Google Scholar 

Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Zuidewijn DBW, Zonderland HM, Tollenaar RAEM, Lobbes MBI, Ausems MGEM, van’t Riet M, Hooning MJ, Mares-Engelberts I, Luiten EJT, Heijnsdijk EAM, Verhoef C, Karssemeijer N, Oosterwijk JC, de Obdeijn IM, Koning HJ (2019) Tilanus-linthorst MMA; FaMRIsc study group MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncol 20(8):1136–1147. https://doi.org/10.1016/S1470-2045(19)30275-X

Article  PubMed  Google Scholar